Pictet Asset Management
VNDA icon

Pictet Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Pictet Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,919,002
Closed -$8.1M – 2027
2023
Q4 		$8.1M Buy
1,919,002
+181,411
+10% +$732K 0.01% 691
2023
Q3 		$7.51M Buy
+1,737,591
New +$9.65M 0.01% 675

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management's VNDA Position: Q1 2024 in Review

Pictet Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2024, closing a stake of 1,919,002 shares — an estimated $8.1M sold.

Pictet Asset Management first reported a position in VNDA in Q3 2023 and held it in 2 quarters. The position peaked at $8.1M in Q4 2023. 144 funds tracked by Wall St. Rank hold VNDA as of Q1 2024.

  • Pictet Asset Management reported no remaining Vanda Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Pictet Asset Management sold 1,919,002 Vanda Pharmaceuticals shares in Q1 2024, an estimated $8.1M.
  • Pictet Asset Management first reported a position in Vanda Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • Pictet Asset Management's Vanda Pharmaceuticals position peaked at $8.1M in Q4 2023.
  • 144 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2024.

Based on Pictet Asset Management's 13F filing for Q1 2024, filed 14 May 2024.